Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity
- Conditions
- Carrier StateRespiratory Infections
- Registration Number
- NCT05474430
- Lead Sponsor
- Philip Polgreen
- Brief Summary
A research team member will brush the inferior surface of the subjects' middle turbinate (nasal cavity) using a cytology brush to obtain the cells needed to perform our functional respiratory assays.
An individual trained in phlebotomy will draw one 3 ml lavender top tube of blood to test c-reactive protein, calprotectin, and lactoferrin. They will also draw a 5 ml gold top serum separator tube of blood to test fibroblast growth factor-19.
The participant will answer questions from the baseline survey and report their current medications interview-style with the research team member.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 160
- Previously tested and shown to be a CF carrier
- English-speaking
Control Group Inclusion Criteria:
- Previously tested and shown to not be a CF carrier or CF patient
- English-speaking
- Currently sick with a respiratory infection
- Prisoner Status
- Unable to provide own written, informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of Bicarbonate Transport Values At baseline Comparison of bicarbonate transport values in cystic fibrosis carrier group vs control group via t-test.
Comparison of Mucous Viscosity Values At baseline Comparison of mucous viscosity values in cystic fibrosis carrier group vs control group via t-test.
Comparison of Chloride Transport Values At baseline Comparison of chloride transport values in cystic fibrosis carrier group vs control group via t-test.
Comparison of Airway Surface Liquid pH Values At baseline Comparison of airway surface liquid pH values in cystic fibrosis carrier group vs control group via t-test.
Comparison of Bacterial Killing Values At baseline Comparison of bacterial killing values in cystic fibrosis carrier group vs control group via t-test.
- Secondary Outcome Measures
Name Time Method Comparison of Fibroblast Growth Factor-19 Values At baseline Comparison of fibroblast growth factor-19 values in cystic fibrosis carrier group vs control group via t-test.
Trial Locations
- Locations (1)
University of Iowa Hospitals and Clinics
🇺🇸Iowa City, Iowa, United States